Shahrin Ahmed: The protection against cervical cancer may be achieved with fewer doses of HPV vaccine
Shahrin Ahmed, a Medical Specialist at the Canadian Cancer Society, shared on X:
”The protection against cervical cancer may be achieved with fewer doses of HPV vaccine.
According to recent research, using a single or two HPV vaccine doses can be just as effective in preventing severe cervical changes as three doses for girls and young women. Global efforts to eradicate cervical cancer could be significantly impacted by the findings.
Over 340,000 deaths will be caused by cervical cancer, which is the fourth most common cancer among women worldwide. Cervical cancer is a public health problem that the WHO aims to eliminate. Achieving 90% vaccination coverage among girls by the age of 15 is one of its key targets by the end of the century.
A database is used for the study that includes information on vaccinations and the incidence of high-grade cervical lesions in women aged 10-35 years from 2006 to 2022. Researchers adjusted for variables such as socioeconomic background and maternal history of severe cervical changes to ensure the results were not influenced.
Young girls who received one or two doses of the HPV vaccine before the age of 17 have been observed to have a higher risk of developing pulmonary fibrosis, according to the results. Those who took three doses had a similar risk of undergoing severe cervical changes. According to the research, there is a potential breakthrough in reducing the amount of vaccine doses needed.
According to the researchers, there is still a need for additional studies to understand the duration of protection and if a booster dose may be required in the future.”
More posts featuring Shahrin Ahmed.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023